Secondary analysis of the COLONPREV trial (53,051 adults aged 50-69): reductions in colorectal cancer mortality and incidence were similar by sex and age for colonoscopy and FIT screening; participation was higher with FIT and risk stayed higher in men.
Secondary analysisn = 53,051
Castells et al. Sex- and Age-Stratified Outcomes of Colonoscopy Versus Faecal Immunochemical Testing: Post-Analysis of the COLONPREV Study